Pharmacology faculty study the effects of STING activating drugs on pancreas cancer cells
Drs. Timothy Donahue and Caius Radu are senior authors of a study using imaging to evaluate STING-activating drugs as a cancer therapy.
Technology developed by Pharmacology faculty used to detect potential life-threatening pregnancy complication
The NanoVelcro Chip, developed by Crump Institute faculty Drs. Hsian-Rong Tseng and Yazhen Zhu, has been identified as a key tool for early screening of placenta accreta spectrum disorder.
The findings are published in Nature Communications.
Drug study led by Pharmacology faculty a potential treatment for COVID-19
Drs. Robert Damoiseaux and Vaithi Arumugaswami co-authored a recent study in Cell Reports on berzosertib, a drug shown to be effective in blocking the coronavirus’s ability to replicate without causing significant harm to cells.
FDA approves prostate cancer imaging technique developed by Pharmacology faculty
The FDA recently granted a New Drug Application (NDA) for a novel prostate cancer imaging approach (PSMA-PET) to UCLA and UCSF, the outcome of a four-year interdepartmental and inter-institutional collaboration. The UCLA cohort was directed by Drs. Johannes Czernin and Jeremie Calais.
Pharmacology faculty part of team receiving $13M from NIH for melanoma research
Dr. Tom Graeber, along with colleagues Drs. Antoni Ribas and Roger Lo, have received a five-year $13 million grant from the National Institutes of Health to better understand melanoma resistance to certain targeted therapies and immunotherapies.